Yes, Rosuvastatin can be combined with Ezetimibe or PCSK9 inhibitors to enhance cholesterol reduction, often used in patients with high cardiovascular risk.

Combining Rosuvastatin with Ezetimibe or PCSK9 inhibitors is effective for patients needing significant lipid reduction, as it targets different cholesterol synthesis pathways.